In PAH, this increase in ET-1 is thought to cause sustained vasoconstriction and stimulates cellular proliferation, cell migration, fibrosis, and hypertrophy (see Vachiery and Davenport, 2009). Here, EDN1 is linked to pulmonary arterial hypertension.